IBM Reinvents the Patient Portal

IBMIBM (NYSE: IBM) announced the next evolution of the patient portal, significantly expanding the types of information, alerts, recommendations and interactive coaching healthcare providers can offer to interact with their patients online.

The IBM Patient Empowerment System goes beyond simply allowing patients to schedule appointments online or access a personal health record. Based on new technology out of IBM Research, this next-generation portal helps patients be more involved in managing their own medical profiles. Healthcare organizations such as hospitals or clinics can host the system, allowing physicians and patients to sign in and benefit from advanced services that prevent harmful drug interactions, send alerts for medical problems, examine genetic profiles to prevent over or under dosage of mediation, and more.

The IBM Patient Empowerment System is a standards-based platform, enabling patients to integrate and manage their healthcare data for all medical needs, receive personalized recommendations or alerts for safer medical treatment, and immediately access data from a vast range of sources including: third-party health portals, hospital electronic medical record systems, sensors, home devices for monitoring health conditions, U.S. Food and Drug Administration (FDA) alerts, medical sites like PubMed, and more. IBM is previewing the system this week at CeBIT in Hanover Germany.

The technology has been developed in collaboration with physicians and administrators of the Gacheon University Gil hospital in Korea. Among the largest medical centers in Korea with approximately one million patients, the hospital recently decided to provide physicians and patients with access to the portal as part of a pilot project to increase efficiency and reduce costs.

"Today, patients want to be more involved in managing their clinical data, and are eager to discover relevant and useful medical information for their benefit," noted Dr. DongKyun Park from Gacheon University Gil Hospital in Korea. "By giving patients access to information that is relevant to them in an easy and understandable form, we can greatly improve patient safety during medical treatments."

The system's easy-to-use analytical services can reduce costs, increase safety and improve patient satisfaction. By integrating social and medical data from multiple sources, the system allows patients to take an active role in their treatment, bringing the interaction between patients and caregivers to a new level of collaborative teamwork.

The system is also designed to protect privacy at various levels of granularity, enabling members to exercise fine-grained control over the level of information in their profile that can be viewed by others and its usage.

"Most patients do not have the same access to information available to physicians, such as treatment updates or new warnings from the FDA," said Joseph Jasinski, IBM Research. "And physicians are not always privy to ongoing patient updates, such as eating habits or long-term monitoring of vital signs. These partial pictures limit the level of care that physicians can provide, as well as the care patients can provide for themselves. The IBM Patient Empowerment System merges these realms, bringing important data to both parties."

Although more public sources for medical information are becoming available on the Internet all the time, this onslaught often leaves patients more confused rather than more knowledgeable. Weeding out relevant and accurate information in this sea of data is difficult for the typical patient but the IBM Patient Empowerment System uses expert analytics to take into account a patient's personal medical history and offer decision support information that is appropriate for them.

One example where public knowledge could improve patient safety involves personalized alerts for adverse drug events (ADE) - incidents where different medications could be dangerous when taken together. The Kaiser Family Foundation estimates that 7,000 people per year die from medication errors alone - about 16 percent more deaths than those attributable to work-related injuries.

ADE contributes greatly to added expenses in hospitalization and insurance costs every year. This service uses the platform's knowledge-bases alongside public repositories for drug-drug, drug-disease, drug-food, and pharmacogenetics interactions; these are then analyzed together with the most current patient clinical and genetic data. The output is an alert that can be given at the point of care to avoid potential harm associated with various drug interactions.

For example, if a patient is already being treated with prescription medicines and wants to take an over-the-counter medication, she would log into the IBM Patient Empowerment System and add the name of the drug to her list of medications. The system immediately crawls through her medical data, performs deep analytics, and then issues a warning message with details about a potentially dangerous interaction between one of the drugs she's already taking and the new one.

Because the system incorporates the patient's genetic profile, it can also issue warnings to the patient and prescribing physician if certain dosages or drug combinations are problematic given her personal genetic variations. Such genetic variations can lead a person to metabolize certain drugs differently than the greater population, raising the risk of dangerous adverse drug reactions. This information might otherwise be unavailable or even unknown to her physician.

Other smart services developed as part of this healthcare portal include socio-medical search and personalized recommendation services. The system maintains a unique dataspace that represents social entities, such as patients and healthcare personnel, and their relationship with medical entities, such as medications, allergies, and treatment plans. The IBM Patient Empowerment System also offers search capabilities and recommendations about patients who suffer from similar problems, potential treatment plans, expert physicians, and more. These features are built on IBM's Big Data Analytics platform, which can process structured and unstructured data at scale and speed not possible with traditional data warehouse technologies, allowing the system to discover relations hidden in the data and correlate with external information.

Because the system is designed as a standards-based clinical data warehouse and supports standard interoperability profiles, it can also immediately incorporate any medical information from sensors, home medical devices, monitoring systems, labs, or hospital information systems. Moreover, this interoperability makes it possible to add new data sources or services at any time.

This solution is just one example of how IBM researchers are helping transform the healthcare industry by creating technologies that will simplify the complex interactions in the healthcare delivery process while optimizing outcomes, ultimately helping to make patient care smarter and lower costs. Another focal area is health analytics, which uses advanced analytic capabilities such as those of IBM's Watson computing system, to produce valuable and timely insight from the vast amount of medical data available. Watson's ability to analyze the meaning and context of human language, and quickly process information to find precise answers can assist decision makers, such as physicians, to unlock important knowledge and facts buried within huge volumes of information, and offer answers they may not have considered to help validate their own ideas or hypotheses. This paves the way for a more evidence-based healthcare system that offers more informed diagnosis and treatment plans for patients at lower costs for providers, insurers and patients.

The IBM Patient Empowerment System was born as a result of the collaboration among three IBM centers around the world: the IBM Ubiquitous Computing Laboratory in Korea; IBM Research - Haifa and IBM Research - China.

Related news articles:

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...